These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 1263405)

  • 1. [Somatostatin -- a review (author's transl)].
    Lucke C; Mitzkat HJ; von zur Mühlen A
    Klin Wochenschr; 1976 Apr; 54(7):293-301. PubMed ID: 1263405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin.
    Efendić S; Hökfelt T; Luft R
    Adv Metab Disord; 1978; 9():367-424. PubMed ID: 347908
    [No Abstract]   [Full Text] [Related]  

  • 3. Somatostatin, basic and clinical studies. A review.
    Schally AV; Meyers CA
    Mater Med Pol; 1980; 12(1-2):28-32. PubMed ID: 6120265
    [No Abstract]   [Full Text] [Related]  

  • 4. [Somatostatin--hormone inhibitor (author's transl)].
    Sieradzki J
    Przegl Lek; 1976; 33(3):393-7. PubMed ID: 1273332
    [No Abstract]   [Full Text] [Related]  

  • 5. Somatostatin: diabetes and acromegaly.
    Gerich JE
    Adv Intern Med; 1977; 22():251-72. PubMed ID: 190870
    [No Abstract]   [Full Text] [Related]  

  • 6. The brain as an endocrine organ.
    Guillemin R
    Neurosci Res Program Bull; 1978 Aug; 16 Suppl():1-25. PubMed ID: 368676
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of somatostatin on thyrotropin, prolactin, growth hormone and insulin responses to thyrotropin releasing hormone and arginine in healthy, hypothyroid and acromegalic subjects.
    Faure N; Dussault JH; Nadeau A; Szots F; Guyda H; Labrie F
    Can Med Assoc J; 1977 Sep; 117(5):478-81. PubMed ID: 409475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin: physiological and clinical significance.
    Guillemin R; Gerich JE
    Annu Rev Med; 1976; 27():379-88. PubMed ID: 779605
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical implications of growth hormone release inhibiting hormone (GH-RIH).
    Besser GM
    Curr Top Mol Endocrinol; 1976; 3():115-25. PubMed ID: 211004
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on growth hormone secretion. VII. Effects of somatostatin on plasma GH, insulin, and glucagon in sheep.
    Bryce D; Yeh M; Funderburk C; Todd H; Hertelendy F
    Diabetes; 1975 Sep; 24(9):842-50. PubMed ID: 169176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical localization of somatostatin.
    Pelletier G
    Prog Histochem Cytochem; 1980; 12(3):1-41. PubMed ID: 6987713
    [No Abstract]   [Full Text] [Related]  

  • 12. [Role of somatostatin in the regulation of GH in rats (author's transl)].
    Wakabayashi I
    Horumon To Rinsho; 1979 May; 27(5):465-71. PubMed ID: 455755
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of somatostatin on gastrin, insulin and glucagon secretion in two patients with Zollinger-Ellison syndrome.
    Fallucca F; Delle Fave G; Giangrande L; Del Balzo P; De Magistris L; Carratù R
    J Endocrinol Invest; 1981; 4(4):451-3. PubMed ID: 6120969
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effects of somatostatin in acromegaly].
    Schaison G; Roger M; Milhaud G
    Nouv Presse Med; 1976 Mar; 5(10):629-32. PubMed ID: 772591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin: analogs with selected biological activities.
    Brown M; Rivier J; Vale W
    Science; 1977 Jun; 196(4297):1467-9. PubMed ID: 867045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of long acting somatostatin analogue SMS 201-995 in acromegaly.
    Choi CJ; Shin DB; Kim SW; Yang IM; Kim JW; Kim YS; Choi YK
    Korean J Intern Med; 1987 Jul; 2(2):176-83. PubMed ID: 3155325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression and stimulation mechanisms controlling glucagon secretion in a case of islet-cell tumor producing glucagon, insulin, and gastrin.
    Tiengo A; Fedele D; Marchiori E; Nosadini R; Muggeo M
    Diabetes; 1976 May; 25(5):408-12. PubMed ID: 5326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative effects of somatostatin and two somatostatin analogues on the release of insulin, glucagon and growth hormone.
    Efendić S; Luft R; Sievertsson H
    FEBS Lett; 1975 Oct; 58(1):302-5. PubMed ID: 1225595
    [No Abstract]   [Full Text] [Related]  

  • 19. [Phe4]somatostatin: a potent, selective inhibitor of growth hormone release.
    Meyers CA; Coy DH; Murphy WA; Redding TW; Arimura A; Schally AV
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):577-9. PubMed ID: 6987657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [PRF activity of VIP in vitro (author's transl)].
    Arancibia S; Enjalbert A; Ruberg M; Priam M; Bluet-Pajot MT; Kordon C
    J Physiol (Paris); 1981 Mar; 77(8):979-83. PubMed ID: 6122734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.